Acid-base balance via bicarbonate precursor

"Acid-base balance via bicarbonate precursor" is not a specific molecular target such as an enzyme, receptor, transporter, or channel. Instead, it refers to the physiological process by which certain administered substances—primarily **lactate**, **acetate**, and sometimes **gluconate**—are metabolized in the body to produce **bicarbonate ions (\(\mathrm{HCO}_3^-\\))**, thereby contributing to acid-base homeostasis. These compounds are commonly included in balanced intravenous fluids used for resuscitation or correction of metabolic acidosis. Lactated Ringer’s solution contains sodium lactate; PlasmaLyte contains sodium acetate and gluconic acid; both provide substrates that are converted into bicarbonates through hepatic metabolism. Acetate is efficiently converted into \(\mathrm{HCO}_3^-\\) even when liver function is impaired[2]. Gluconates are less effective because they tend to be excreted rather than metabolized for buffering purposes[2][4]. This entry does not correspond to a single protein or gene product but rather describes a therapeutic strategy using metabolic intermediates as buffers. Therefore, it should not be considered a canonical drug target. > "Acetate-buffered balanced fluids show superior buffering effects compared with Ringer's lactated or saline... Acetatemay be the most efficientbicarbonat eprecursor"[2]. > "Commonly used 'bicarbon ateprecursors' include sodium acetate... The conjug atebaseofaceticacid..."[4] Because this term does not refer to an individual molecule/receptor/protein but instead describes a general mechanism involving multiple metabolites and organ systems (mainly liver metabolism), it is considered incorrect as an entry for molecular drug targets.

Bicarbonate precursors such as lactate and acetate are metabolized in the body to generate bicarbonate ions, which buffer excess hydrogen ions and help restore physiological pH[2][4].